Ignite Creation Date:
2025-12-25 @ 2:45 AM
Ignite Modification Date:
2026-02-25 @ 9:45 PM
Study NCT ID:
NCT02504333
Status:
COMPLETED
Last Update Posted:
2023-10-03
First Post:
2015-07-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I/II Study of Nab-paclitaxel and Gemcitabine Followed by AG-mFOLFOX in Patients With Metastatic Pancreatic Adenocarcinoma
Sponsor:
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
TTD-14-05
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None